MONKEYPOX (MPOX) DIAGNOSIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Key Takeaways from Analyst
The recent monkeypox outbreak has boosted the demand for reliable diagnostics, with North America leading due to high case numbers. polymerase chain reaction tests, the primary diagnostic method, are offered by companies like Roche, Abbott, and BioMerieux, but require specialized labs and processing time, creating a need for faster solutions. Point-of-care antigen tests are gaining interest but face regulatory and funding challenges. Additionally, symptom overlap with conditions like chickenpox and undetected rashes complicates accurate diagnosis, highlighting the potential for combined DNA and antibody detection.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
